Acupuncture Treatment for Schizophrenia-related Central Obesity

Change from Baseline Body Weight Index at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively

weight and height will be combined to report BMI in kg/m\^2

Time frame: Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks

Change from Baseline Hip Circumference at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively

Hip Circumference in centimiter

Time frame: Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks

Change from Baseline both Blood Pressure at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively

both Blood Pressure in mm/Hg

Time frame: Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks

Change from Baseline Blood Triglyceride at 16 weeks, 32 weeks, respectively

Blood Triglyceride in mmol/L

Time frame: Baseline, 16 weeks, 32 weeks

Change from Baseline Blood Total Cholesterol at 16 weeks, 32 weeks, respectively

Total Cholesterol in mmol/L

Time frame: Baseline, 16 weeks, 32 weeks

Change from Baseline Blood Low-density Lipoprotein at 16 weeks, 32 weeks, respectively

Blood Low-density Lipoprotein in mmol/L

Time frame: Baseline, 16 weeks, 32 weeks

Change from Baseline Blood High-density Lipoprotein at 16 weeks, 32 weeks, respectively

Blood High-density Lipoprotein in mmol/L

Time frame: Baseline, 16 weeks, 32 weeks

Change from Baseline Blood Glucose at 16 weeks, 32 weeks, respectively

Blood Glucose in mmol/L

Time frame: Baseline, 16 weeks, 32 weeks

Change from Baseline Positive And Negative Syndrome Scale at 8 weeks, 20 weeks, 32 weeks, respectively

The Positive And Negative Syndrome Scale is used for valuation of positive symptom, negative symptom and general symptom of patients with schizophrenia. The score range of Positive And Negative Syndrome Scale is 0 to 150. The higher the score, the more severe the psychiatric symptoms.

Time frame: Baseline, 8 weeks, 20 weeks, 32 weeks

Change from Baseline Clinical Global Impression at 8 weeks, 20 weeks, 32 weeks, respectively

The Clinical Global Impression evaluates the severity of ilness, global improvement and efficacy index. The score range of severity of ilness is 0 (none) to 7 (extremly severe). The score range of global improvement is 0 (none) to 7 (seriously deteriorated). The score range of efficacy index is 0 (none) to 4 (effective and no adverse effect).

Time frame: Baseline, 8 weeks, 20 weeks, 32 weeks

Change from Baseline Personal and Social Performance Scale at 8 weeks, 20 weeks, 32 weeks, respectively

The score range of Personal and Social Performance Scale is 1 to 100. The higher score, the better personal and social performance.

Time frame: Baseline, 8 weeks, 20 weeks, 32 weeks

Change from Baseline Appetite visual analogue scale at 8 weeks, 20 weeks, 32 weeks, respectively

The score range of Appetite visual analogue scale is 0 to 10. The higher score, the better appetite.

Time frame: Baseline, 8 weeks, 20 weeks, 32 weeks

Change from Baseline Treatment Emergent Symptom Scale at 8 weeks, 16 weeks, 20 weeks, 32 weeks, respectively

The Treatment Emergent Symptom Scale contains 34 different common adverse effects in psychiatry patients. Each adverse effect can be assessed from three aspects, which are serverity, relationship with medications, and mesurement taken. The score range of serverity is 0 (none) to (servere). The range of relationship with medication is none, basicly (likelihood 10%) , maybe (likelihood 10%-50%), very likely (likelihood 50%-80%), definitely (likelihood over 90%). The score range of measurement taken is 0 (none) to 5 (stop medication).

Time frame: Baseline, 8 weeks, 16 weeks, 20 weeks, 32 weeks